Eduard Vieta has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, AbbVie, Adamed, Alcediag, Angelini, Biogen, Beckley-Psytech, Biohaven, Boehringer-Ingelheim, Casen-Recordati, Celon Pharma, Clariane, Compass, Dainippon Sumitomo Pharma, Esteve, Ethypharm, Ferrer, Gedeon Richter, GH Research, Glaxo-Smith Kline, HMNC, Intra-Cellular therapies, Idorsia, Johnson & Johnson, Lundbeck, Luye Pharma, Medincell, Merck, Mitsubishi Tanabe Pharma, Newraxpharm, Newron, Novartis, Organon, Orion Corporation, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris, outside the submitted work
It was first characterized by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, and a 2025 literature and patent review cataloged its effects across gastrointestinal, musculoskeletal, and neural models
While no supplement can replace prescription GLP-1 therapy, the right ingredients can help support appetite control, digestive comfort, metabolic health, and essential nutrient intake.* Below is a guide to the best OTC GLP-1friendly supplements, plus key ingredients to look for
Maintaining adequate hydration, dietary fibre intake, and monitoring bowel habits are prudent measures for anyone with known diverticula, regardless of medication use
The best time to take your weekly injection is whenever you will remember it consistently, though many researchers prefer mornings
doi: 10.1016/S0015-0282(02)04237-1 62 Abd-ElmoatyMASalehRSharmaRAgarwalA